Approaches for genomic mapping of 5-hydroxymethylcytosine a novel epigenetic mar

新型表观遗传标记 5-羟甲基胞嘧啶的基因组作图方法

基本信息

  • 批准号:
    8142978
  • 负责人:
  • 金额:
    $ 17.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-14 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Over the last decade, epigenetic phenomena have claimed a central role in the research of cell regulatory processes. In addition, there is increasing evidence that epigenetic factors may play a significant role in various human diseases. One of the best understood epigenetic mechanisms is DNA methylation. In the mammalian genome, cytosines (C) are known to exist in two functional states: unmethylated or methylated at the 5-position of the pyrimidine ring (5mC). Cytosines followed by guanine (CpG dinucleotides) are the preferred targets for methylation. Recent studies of genomic DNA from the human brain, neurons and from mouse embryonic stem cells detected evidence that CG sequences also contain 5- hydroxymethylcytosine (hmC). As their interactions with cellular proteins are distinct, the 5- hydroxymethyl groups in DNA do not merely mimic 5-methyl groups, but likely play an independent role in yet unknown epigenetic regulation of various biological processes, such as embryonic development, brain function, and cancer progression. However, further studies of these intriguing phenomena are hampered by the lack of adequate analytical techniques. A myriad of methods have been developed over the past several years to investigate DNA methylation profiles across large DNA regions - chromosomes and even entire genomes. All such methods are binary - i.e., designed to distinguish only the two epigenetic states of cytosine: methylated versus unmodified. This project is dedicated to the development of new technologies that are capable of unequivocal mapping of hmC in mammalian genomes. Our strategy is based on utilization of known and newly discovered enzymatic transformations of the hydroxylmethyl group in hmC to achieve selective detection and capture of hmC-containing genomic fragments. Combining these novel approaches with DNA microarray analyses, we will perform epigenome-wide mapping of hmC in the human brain. Finally, we will perform nucleotide-resolution mapping of hmC at selected loci to unveil the intra- and inter- individual variation of this novel cytosine modification in DNA. PUBLIC HEALTH RELEVANCE: Changes in DNA methylation patterns may predispose individuals to various human diseases, including cancer, schizophrenia, autism, asthma, and diabetes. Research into the epigenetic misregulation in human disease is hampered by the lack of adequate laboratory techniques. Our new technologies for the analysis of the 6th base, namely 5-hydroxymethylcytosine, will be an incredibly valuable addition to the "tool box" of comprehensive genomic studies.
描述(由申请人提供):在过去的十年中,表观遗传现象在细胞调控过程的研究中发挥了核心作用。此外,越来越多的证据表明,表观遗传因素可能在各种人类疾病中发挥重要作用。最好理解的表观遗传机制之一是DNA甲基化。在哺乳动物基因组中,胞嘧啶(C)已知以两种功能状态存在:未甲基化或在嘧啶环的5位甲基化(5mC)。胞嘧啶之后是鸟嘌呤(CpG二核苷酸)是甲基化的优选靶标。最近对人脑、神经元和小鼠胚胎干细胞基因组DNA的研究发现,CG序列也含有5-羟甲基胞嘧啶(hmC)。由于它们与细胞蛋白质的相互作用是不同的,DNA中的5-羟甲基基团不仅模拟5-甲基基团,而且可能在各种生物过程的未知表观遗传调控中发挥独立作用,例如胚胎发育,脑功能和癌症进展。然而,由于缺乏足够的分析技术,对这些有趣现象的进一步研究受到阻碍。在过去的几年里,已经开发了无数的方法来研究大DNA区域-染色体甚至整个基因组-的DNA甲基化谱。所有这些方法都是二进制的,即,旨在区分胞嘧啶的两种表观遗传状态:甲基化与未修饰。 该项目致力于开发能够在哺乳动物基因组中明确定位hmC的新技术。我们的策略是基于利用已知的和新发现的酶促转化的羟甲基在hmC实现选择性检测和捕获的hmC-含有基因组片段。将这些新方法与DNA微阵列分析相结合,我们将在人脑中进行hmC的表观基因组范围的映射。最后,我们将在选定的基因座进行hmC的核苷酸分辨率作图,以揭示这种新的DNA胞嘧啶修饰的个体内和个体间变异。 公共卫生关系:DNA甲基化模式的变化可能使个体易患各种人类疾病,包括癌症、精神分裂症、自闭症、哮喘和糖尿病。由于缺乏足够的实验室技术,对人类疾病中表观遗传失调的研究受到阻碍。我们用于分析第六个碱基(即5-羟甲基胞嘧啶)的新技术将成为全面基因组研究“工具箱”的一个非常有价值的补充。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Methyltransferase-directed derivatization of 5-hydroxymethylcytosine in DNA.
  • DOI:
    10.1002/anie.201007169
  • 发表时间:
    2011-02-25
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Liutkeviciute, Zita;Kriukiene, Edita;Grigaityte, Indre;Masevicius, Viktoras;Klimasauskas, Saulius
  • 通讯作者:
    Klimasauskas, Saulius
5-Hydroxymethylcytosine--the elusive epigenetic mark in mammalian DNA.
  • DOI:
    10.1039/c2cs35104h
  • 发表时间:
    2012-11-07
  • 期刊:
  • 影响因子:
    46.2
  • 作者:
    Kriukienė E;Liutkevičiūtė Z;Klimašauskas S
  • 通讯作者:
    Klimašauskas S
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Saulius Klimasauskas其他文献

Saulius Klimasauskas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Saulius Klimasauskas', 18)}}的其他基金

Direct single nucleotide mapping of genomic CpG marks
基因组 CpG 标记的直接单核苷酸作图
  • 批准号:
    8651509
  • 财政年份:
    2013
  • 资助金额:
    $ 17.1万
  • 项目类别:
Direct single nucleotide mapping of genomic CpG marks
基因组 CpG 标记的直接单核苷酸作图
  • 批准号:
    8489384
  • 财政年份:
    2013
  • 资助金额:
    $ 17.1万
  • 项目类别:
Approaches for genomic mapping of 5-hydroxymethylcytosine a novel epigenetic mar
新型表观遗传标记 5-羟甲基胞嘧啶的基因组作图方法
  • 批准号:
    7874207
  • 财政年份:
    2010
  • 资助金额:
    $ 17.1万
  • 项目类别:

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 17.1万
  • 项目类别:
    Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
    Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
    Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
  • 批准号:
    10723233
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
  • 批准号:
    10723861
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
  • 批准号:
    10586398
  • 财政年份:
    2023
  • 资助金额:
    $ 17.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了